07/29/2015 - 12:31pm

Among the nearly 400 manufacturers, automation, sofware and pharmacy business vendors on the trade show foor at the Cardinal Health Retail Business Conference this week were several important pharmacy solutions.

07/29/2015 - 12:27pm

The Consumer Healthcare Products Association expressed support for the DXM Abuse Prevention Act, introduced into the U.S. House of Representatives by U.S. Reps. Bill Johnson, R-Ohio, and Doris Matsui, D-Calif., on Wednesday.

07/29/2015 - 11:35am

Customer Appreciation Night: Through the Decades was a celebration of 25 years at RBC. With surprises around every corner, this celebration allowed customers to turn back time. The celebration included dinner, dessert and a "Through the Decades" show.

07/29/2015 - 10:48am

Hikma Pharmaceuticals on Wednesday announced its acquisition of Roxane Laboratories and Boehringer Ingelheim Roxane (together, “Roxane” — an American specialty generics company) from Boehringer Ingelheim for about $2.65 billion.

07/28/2015 - 11:46am

Voters from all political parties support sunshine legislation that would make promote transparency in generic prescription drug payments by pharmacy benefit manager corporations, according to a national survey from the National Community Pharmacists Association released Tuesday.

07/28/2015 - 11:40am

In its largest acquisition to date, medical equipment manufacturer Drive Medical acquired DeVilbiss Healthcare from Vestar Capital Partners in early July.

07/28/2015 - 11:00am

Sandoz on Tuesday announced the launch of a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) in 1-mg strength. Sandoz expects to have 180-day generic drug marketing exclusivity for the 1-mg strength.

07/28/2015 - 10:55am

The National Association of Chain Stores commented this week on the Centers for Medicare and Medicaid Services’ proposed regulations guiding the use of managed care in Medicaid and in the Children’s Health Insurance Program.

07/28/2015 - 6:26am

A GAO report released Monday suggests that the Drug Enforcement Agency should take steps to improve communications with pharmacists, manufacturers.